Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1972 1
1979 3
1983 4
1984 1
1985 2
1986 1
1988 3
1989 4
1990 4
1991 9
1992 6
1993 4
1994 11
1995 1
1996 5
1997 2
1998 1
1999 2
2000 4
2001 3
2002 6
2003 4
2004 7
2005 7
2006 7
2007 16
2008 10
2009 17
2010 14
2011 17
2012 18
2013 12
2014 7
2015 14
2016 21
2017 16
2018 14
2019 12
2020 13
2021 12
2022 12
2023 14
2024 16
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

322 results

Results by year

Filters applied: . Clear all
Page 1
Usefulness of Repeated Lusutrombopag Administration in Clinical Practice and its Correlation with the Simulation Software-Predicted Platelet Count: A Multicenter Study.
Manabe T, Ogawa C, Tamada T, Yoshioka N, Akahane T, Fujii H, Arai H, Takuma K, Nakahara M, Oura K, Tadokoro T, Fujita K, Tani J, Morishita A, Kobara H, Nakamura S, Ochi H, Takaki S, Mori N, Tsuji K, Kurosaki M, Izumi N. Manabe T, et al. Among authors: takaki s. Intern Med. 2025 Mar 15. doi: 10.2169/internalmedicine.4822-24. Online ahead of print. Intern Med. 2025. PMID: 40090722 Free article.
Discrepancy between Subjective and Objective Measurements for the Evaluation of Medication Adherence-A Cross-Sectional Study in Patients with Cardiovascular Diseases.
Miyazaki M, Hirata H, Takaki S, Misaki M, Mori Y, Tokura K, Sato N, Nakashima A, Yanagida A, Okajima I, Urata H, Imakyure O. Miyazaki M, et al. Among authors: takaki s. Pharmacy (Basel). 2024 Oct 6;12(5):153. doi: 10.3390/pharmacy12050153. Pharmacy (Basel). 2024. PMID: 39452809 Free PMC article.
The polymyxin-B direct hemoperfusion OPTimal Initiation timing with Catecholamine PMX-OPTIC study: A multicenter retrospective observational study.
Nakamura K, Okazaki T, Tampo A, Mochizuki K, Kanda N, Ono T, Yanagita K, Shimomura T, Murase T, Saito K, Hirayama T, Ito T, Ogawa K, Nakamura M, Oda T, Morishima T, Fukushima T, Yasui H, Akashi N, Oshima K, Kawarazaki H, Akiba T, Uemura S, Honma Y, Nitta K, Okamoto K, Takaki S, Takeda H, Yamashita C. Nakamura K, et al. Among authors: takaki s. Artif Organs. 2025 Feb;49(2):218-228. doi: 10.1111/aor.14865. Epub 2024 Sep 18. Artif Organs. 2025. PMID: 39291793
Treatment response to durvalumab plus tremelimumab after progression with previous immune checkpoint inhibitor in unresectable hepatocellular carcinoma.
Mori N, Tamaki N, Takaki S, Tsuji K, Tada T, Nakamura S, Ochi H, Mashiba T, Doisaki M, Marusawa H, Kobashi H, Fujii H, Ogawa C, Nonogi M, Arai H, Uchida Y, Urawa N, Narita R, Akahane T, Kondo M, Yasui Y, Tsuchiya K, Izumi N, Kurosaki M. Mori N, et al. Among authors: takaki s. Invest New Drugs. 2024 Oct;42(5):559-565. doi: 10.1007/s10637-024-01470-y. Epub 2024 Aug 30. Invest New Drugs. 2024. PMID: 39212893
Change in Liver Function in Durvalumab Plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma.
Tamaki N, Mori N, Takaki S, Tsuji K, Tada T, Nakamura S, Ochi H, Mashiba T, Doisaki M, Marusawa H, Kobashi H, Fujii H, Ogawa C, Nonogi M, Arai H, Uchida Y, Urawa N, Narita R, Akahane T, Kondo M, Yasui Y, Tsuchiya K, Izumi N, Kurosaki M. Tamaki N, et al. Among authors: takaki s. Anticancer Res. 2024 Sep;44(9):3913-3918. doi: 10.21873/anticanres.17219. Anticancer Res. 2024. PMID: 39197893
Assessing the ability of the Cancer and Aging Research Group tool to predict chemotherapy toxicity in older Japanese patients: A prospective observational study.
Uchiyama M, Miyazaki M, Hayashi T, Shimokawa M, Nakano T, Kakimoto H, Takaki S, Fukue H, Inoue T, Inoue R, Mashima K, Kawata S, Sumi Y, Igarashi Y, Kamimura H, Imakyure O, Matsuo K. Uchiyama M, et al. Among authors: takaki s. J Geriatr Oncol. 2024 Jul;15(6):101814. doi: 10.1016/j.jgo.2024.101814. Epub 2024 Jun 7. J Geriatr Oncol. 2024. PMID: 38851083 Free article.
Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter study.
Morita A, Tamaki N, Kobashi H, Mori N, Tsuji K, Takaki S, Hasebe C, Akahane T, Ochi H, Mashiba T, Urawa N, Fujii H, Mitsuda A, Kondo M, Ogawa C, Uchida Y, Narita R, Marusawa H, Kubotsu Y, Matsushita T, Shigeno M, Yoshida H, Tanaka K, Okamoto E, Kasai T, Ishii T, Okada K, Kurosaki M, Izumi N. Morita A, et al. Among authors: takaki s. JGH Open. 2024 Apr 25;8(4):e13068. doi: 10.1002/jgh3.13068. eCollection 2024 Apr. JGH Open. 2024. PMID: 38681824 Free PMC article.
322 results